Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

34.34
+0.68772.04%
Post-market: 33.65-0.6880-2.00%16:04 EDT
Volume:2K
Turnover:54.52K
Market Cap:13.74M
PE:- -
High:34.34
Open:33.65
Low:33.65
Close:33.65
52wk High:34.98
52wk Low:27.25
Shares:400.00K
Float Shares:400.00K
Volume Ratio:0.76
T/O Rate:0.40%
Dividend:0.08
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Verici Dx closes accelerated bookbuild for new share placing

TIPRANKS
·
Yesterday

What Do Johnson & Johnson (JNJ) Trial Wins Mean For Its Drug Pipeline?

Simply Wall St.
·
Yesterday

Medibank names digital health expert for board ahead of 2026 AGM

TIPRANKS
·
Yesterday

Edwards Lifesciences CVP, TAVR Daniel J. Lippis Disposes of 619 Common Shares for $53,017.35

Reuters
·
Yesterday

Biogen Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Yesterday

Edwards Lifesciences Corp. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Yesterday

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Verici Dx launches £8m share placing to fund U.S. transplant diagnostics push

TIPRANKS
·
Yesterday

Dow's Nearly 150-Point Fall Led by Losses for Shares of Amgen, Johnson & Johnson

Dow Jones
·
Oct 08

Lepu Medical's Subsidiary Gains FDA Clearance for Clinical Trial of MWN117 Injection

Stock News
·
Oct 08

Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
Oct 08

Zhongsheng Pharmaceutical's Class 1 Innovative Drug RAY1225 Injection Achieves Topline Analysis Results in Phase III Weight Loss Clinical Trial

Stock News
·
Oct 08

All Invest Securities Reaffirms Buy Rating on ABL Texcell Diagnostics as Texcell Integration Boosts Growth Outlook

TIPRANKS
·
Oct 08

Merck & Company (MRK) Receives a Buy from BMO Capital

TIPRANKS
·
Oct 08

Cerenome Secures In-Network Agreement with Florida Blue for CNSide® CSF Tumor Cell Enumeration and Molecular Profile Tests

GlobeNewswire
·
Oct 08

Tiantan Biological's Subsidiary Secures Clinical Trial Summary Report for Human Coagulation Factor IX

Stock News
·
Oct 08

Biogen : RBC Cuts Target Price to $256 from $260

THOMSON REUTERS
·
Oct 08

Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and NeoGenomics (NEO)

TIPRANKS
·
Oct 08

Did Abbott Laboratories' Fall Catch You Out? What Investors Missed

Simply Wall St.
·
Oct 08

Health Care up on Defensive Bias

Dow Jones
·
Oct 08